Presented By: DRI's Medical Liability and Health Care Law Committee

Healthcare-related personnel, facilities, and manufacturers are vital to fighting the novel COVID-19 disease, and the healthcare system requires flexibility to react fluidly to this uncertain situation. Governments at the federal, state and local levels have put some protections for healthcare providers in place, including providing immunity for actions or inactions associated with COVID-19 and suspending certain provisions regulatory provisions for covered entities. This webinar will address the current status of immunity declarations and how it may affect healthcare litigation. The webinar will also discuss which relevant federal regulatory provisions have been amended in response to the COVID-19 crisis, and how it affects both the healthcare system and the legal community. Finally, this webinar will discuss anticipated ways that plaintiffs’ counsel will attempt to circumvent these protections once the immediate crisis is over. 

Who Should Attend: 

• Attorneys who practice healthcare regulatory and/or litigation (such as medical or ALF\SNF litigation)
• Healthcare insurance carriers and their adjusters
• Healthcare risk managers and facility leadership

What Will You Learn?:

• An overview of the immunities put forth in both federal and state orders
• An overview of the regulatory provisions - such as HIPAA, CMS Conditions of Participation, EMTALA, etc. - that have been temporarily amended in response to the COVID-19 crisis
• The types of litigation that may be expected as a result of the COVID-19 crisis (including the type of lawsuits expected to be brough by or against healthcare providers)